Search Results - "Rubié, Hervé"
-
1
Increased Risk of Systemic Relapses Associated With Bone Marrow Micrometastasis and Circulating Tumor Cells in Localized Ewing Tumor
Published in Journal of clinical oncology (01-01-2003)“…The presence of metastasis is a major prognostic factor in Ewing tumor (ET). The relapse pattern of patients with localized tumors has long indicated that…”
Get full text
Journal Article -
2
Progression-Free Survival in Children With Optic Pathway Tumors: Dependence on Age and the Quality of the Response to Chemotherapy—Results of the First French Prospective Study for the French Society of Pediatric Oncology
Published in Journal of clinical oncology (15-12-2003)“…To evaluate a strategy aimed at avoiding radiotherapy during first-line treatment of children with progressive optic pathway tumors (OPT), by exclusively…”
Get full text
Journal Article -
3
Results of Induction Chemotherapy in Children Older Than 1 Year With a Stage 4 Neuroblastoma Treated With the NB 97 French Society of Pediatric Oncology (SFOP) Protocol
Published in Journal of clinical oncology (20-01-2005)“…To test the metastatic response rate in stage 4 neuroblastoma, using dose-intensive induction chemotherapy in a multi-institutional setting. From 1998 to 1999,…”
Get full text
Journal Article -
4
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
Published in Journal of clinical oncology (01-03-2009)“…For a comprehensive overview of the genetic alterations of neuroblastoma, their association and clinical significance, we conducted a whole-genome DNA copy…”
Get full text
Journal Article -
5
Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without MYCN Gene Amplification
Published in Journal of clinical oncology (01-03-2009)“…On the assumption that most infants with disseminated neuroblastoma without MYCN amplification (MYCNA) have a favorable prognosis, two concomitant prospective…”
Get full text
Journal Article -
6
Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
Published in Journal of clinical oncology (01-07-2010)“…Neuroblastoma is characterized by two distinct types of genetic profiles, consisting of either numerical or segmental chromosome alterations. The latter are…”
Get full text
Journal Article -
7
Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma Without MYCN Amplification: Results of the Prospective INES 99.1
Published in Journal of clinical oncology (01-02-2011)“…To evaluate the efficacy of low-dose chemotherapy in infants with nonmetastatic and unresectable neuroblastoma (NB) without MYCN amplification. Infants with…”
Get full text
Journal Article -
8
Poor Survival for Infants With MYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
Published in Journal of clinical oncology (01-03-2009)“…To report the results of a prospective, nonrandomized European study on infants with neuroblastoma and MYCN gene amplification. Infants with neuroblastoma…”
Get full text
Journal Article -
9
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
Published in Journal of clinical oncology (10-11-2009)“…Ifosfamide is widely used in pediatric oncology but its nephrotoxicity may become a significant issue in survivors. This study is aimed at evaluating the…”
Get full text
Journal Article -
10
Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study
Published in Pediatric blood & cancer (01-01-2020)“…Aim To assess objective response after two cycles of temozolomide and topotecan (TOTEM) in children with refractory or relapsed miscellaneous extracranial…”
Get full text
Journal Article -
11
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study
Published in European journal of cancer (1990) (01-01-2014)“…Abstract Purpose To assess objective response rate (ORR) after two cycles of temozolomide in combination with topotecan (TOTEM) in children with refractory or…”
Get full text
Journal Article -
12
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project
Published in European journal of cancer (1990) (01-03-2011)“…Abstract Purpose Increasing age has been an adverse risk factor in children with neuroblastoma (NB) since the 1970’s, with a 12-month age-at-diagnosis cut-off…”
Get full text
Journal Article -
13
Impact of High-Dose Busulfan Plus Melphalan As Consolidation in Metastatic Ewing Tumors: A Study by the Société Française des Cancers de l'Enfant
Published in Journal of clinical oncology (20-08-2006)“…To improve the prognosis for patients with metastatic Ewing sarcoma/primitive neuroectodermal tumors (ES/PNET) using conventional chemotherapy and…”
Get full text
Journal Article -
14
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Published in The lancet oncology (01-07-2009)“…Summary Background More accurate prognostic assessment of patients with neuroblastoma is required to better inform the choice of risk-related therapy. The aim…”
Get full text
Journal Article -
15
Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy
Published in Pediatric blood & cancer (01-06-2014)“…ABSTRACT Background To evaluate long‐term survival of the first cohort of stage‐4 neuroblastoma patients treated with the N7 induction chemotherapy, surgery of…”
Get full text
Journal Article -
16
Long-term side effects of radiotherapy for pediatric localized neuroblastoma
Published in Strahlentherapie und Onkologie (2015)“…Introduction - Neuroblastoma (NB) is the most frequent indication for extracranial pediatric radiotherapy. As long-term survival of high-risk localized NB has…”
Get full text
Journal Article -
17
Long-term side effects of radiotherapy for pediatric localized neuroblastoma: Results from clinical trials NB90 and NB94
Published in Strahlentherapie und Onkologie (01-07-2015)“…Introduction Neuroblastoma (NB) is the most frequent indication for extracranial pediatric radiotherapy. As long-term survival of high-risk localized NB has…”
Get full text
Journal Article -
18
Clinical picture and treatment of 2212 patients with common variable immunodeficiency
Published in Journal of allergy and clinical immunology (01-07-2014)“…Background Common variable immunodeficiency (CVID) is an antibody deficiency with an equal sex distribution and a high variability in clinical presentation…”
Get full text
Journal Article -
19
Late sequelae of symptomatic epidural compression in children with localized neuroblastoma
Published in Pediatric blood & cancer (01-09-2011)“…Background To describe late sequelae and their correlation with presenting clinical features and tumor treatment in children with symptomatic epidural…”
Get full text
Journal Article -
20
Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance
Published in American journal of clinical pathology (01-01-1995)“…Bone marrow involvement by anaplastic large cell anaplastic large cell (ALC) lymphoma can be difficult to detect on routine morphologic examination alone. In a…”
Get more information
Journal Article